|
| Press Releases |
|
 |
|
| Friday, January 15, 2021 |
|
|
Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
| Friday, November 27, 2020 |
|
|
Jacobson Pharma Announces FY2021 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2020 (the "reporting period"). more info >> |
|
| Wednesday, September 23, 2020 |
|
|
Jacobson Pharma Submits Form A1 to Spin-off Its Branded Healthcare Business |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or "the Group"; Stock Code: 2633.HK), a leading company engaged in the research, development, production, marketing and sale of essential medicines and branded healthcare products in Hong Kong more info >> |
|
| Thursday, August 27, 2020 |
|
|
Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE's COVID-19 Vaccine Candidate in Hong Kong and Macau |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or "the Group"; Stock Code: 2633.HK), a leading company engaged in the research, development, production, marketing and sale of essential medicines and branded healthcare products in Hong Kong, today announced the signing of a letter of intent ("Letter of Intent") with Fosun Industrial Co. Ltd. more info >> |
|
| Tuesday, June 30, 2020 |
|
|
Jacobson Pharma Announces FY2020 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2020 (the "FY2020" or the "Reporting Period"). more info >> |
|
| Wednesday, February 5, 2020 |
|
|
Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and branded healthcare products more info >> |
|
| Tuesday, November 26, 2019 |
|
|
Jacobson Pharma Announces FY2020 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2019 (the "reporting period"). more info >> |
|
| Tuesday, November 12, 2019 |
|
|
Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
| Tuesday, November 5, 2019 |
|
|
Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The Netherlands) |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
| Thursday, October 31, 2019 |
|
|
Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced
Feb 10, 2026 19:29 HKT/SGT
|
|
|
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong
Feb 10, 2026 18:14 HKT/SGT
|
|
|
">
Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season
Feb 10, 2026 18:25 JST
|
|
|
CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion
Feb 10, 2026 17:02 HKT/SGT
|
|
|
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business
Feb 10, 2026 17:53 JST
|
|
|
KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System
Feb 10, 2026 14:15 JST
|
|
|
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China
Feb 10, 2026 13:34 JST
|
|
|
Spritzer EcoPark Gallops into the Year of the Horse with a Tradition-Inspired Chinese New Year Celebration
Feb 10, 2026 11:49 HKT/SGT
|
|
|
Mint Signed MoU with Robotics Leader Rice Robotics to Pioneer Physical AI Solutions Across Asia
Feb 10, 2026 09:43 HKT/SGT
|
|
|
NEC Exhibits at MWC Barcelona 2026, the World's Largest Mobile-Related Exhibition
Feb 9, 2026 21:18 JST
|
|
|
CITIC Telecom CPC Wins Two Awards, Celebrating 'Innovation Never Stops' for 25 Years, recognizing Cybersecurity & Innovation Excellence
Feb 9, 2026 14:28 JST
|
|
|
JCB Announces Collaboration with Resorts World Sentosa in Singapore
Feb 9, 2026 14:00 JST
|
|
|
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026
Feb 9, 2026 11:00 JST
|
|
|
playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group 
Feb 8, 2026 23:30 HKT/SGT
|
|
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
